Jane Street Group, LLC Regenxbio Inc. Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 16, 2022	SELL	$19.35 - $35.04 $129,645 - $234,768	-6,700 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$24.62 - $34.31 $9,848 - $13,724	400 Added 6.35%	6,700 $222,000
Q4 2021 Feb 15, 2022	SELL	$30.19 - $40.28 $7.13 Million - $9.51 Million	-236,100 Reduced 97.4%	6,300 $206,000
Q3 2021 Nov 16, 2021	BUY	$29.09 - $45.68 $6.43 Million - $10.1 Million	220,900 Added 1027.44%	242,400 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $480,408 - $599,104	14,800 Added 220.9%	21,500 $835,000
Q1 2021 May 18, 2021	BUY	$33.61 - $49.95 $225,187 - $334,665	6,700 New	6,700 $229,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $439M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.